1. Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways
- Author
-
Chung Soo Lee, Sang Won Kwak, Jeong Jae Lee, Min Sung Lee, Wonyong Kim, Yun Jeong Kim, Eon Sob Park, Soon Chul Myung, and Seon Ae Lee
- Subjects
Programmed cell death ,Indazoles ,Licochalcone A ,Poly (ADP-Ribose) Polymerase-1 ,Apoptosis ,Carcinoma, Ovarian Epithelial ,chemistry.chemical_compound ,Chalcones ,Cell Line, Tumor ,Ovarian carcinoma ,Survivin ,Humans ,Drug Interactions ,Neoplasms, Glandular and Epithelial ,Caspase ,Cell Nucleus ,Ovarian Neoplasms ,Pharmacology ,biology ,Carcinoma ,Antineoplastic Agents, Phytogenic ,Neoplasm Proteins ,Cell biology ,Enzyme Activation ,chemistry ,Guanylate Cyclase ,Cell culture ,Caspases ,Proteolysis ,Cancer cell ,biology.protein ,Cancer research ,Female ,Poly(ADP-ribose) Polymerases ,Tumor Suppressor Protein p53 ,Apoptosis Regulatory Proteins ,Signal Transduction - Abstract
Natural phenol licorice compounds have been shown to induce apoptosis in cancer cells. 3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) may enhance the sensitivity of cancer cells to anticancer drugs. However, the combined effect of licochalcone A and YC-1 on cell death in ovarian cancer cells has not been studied. We assessed the combined effect of licochalcone A and YC-1 on apoptosis in human epithelial ovarian carcinoma cell lines in relation to the cell death process. In the OVCAR-3 and SK-OV-3 cell lines, licochalocone A induced a decrease in Bid, Bcl-2, Bcl-xL and survivin protein levels; an increase in Bax levels; loss of the mitochondrial transmembrane potential; cytochrome c release; activation of caspases (-8, -9 and -3); cleavage of PARP-1; and an increase in the tumor suppressor p53 levels. YC-1 enhanced licochalcone A-induced apoptosis-related protein activation, nuclear damage and cell death. These results suggest that YC-1 may potentiate the apoptotic effect of licochalcone A on ovarian carcinoma cell lines by increasing the activation of the caspase-8- and Bid-dependent pathway and the mitochondria-mediated apoptotic pathway, leading to caspase activation. The combination of licochalcone A and YC-1 may confer a benefit in the treatment of human epithelial ovarian adenocarcinoma.
- Published
- 2012